Jonathan Melamed

5PUBLICATIONS
29CO-AUTHORS
Regenerative medicine (incl. stem cells)Molecular targetsCancer diagnosisPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 17, 2024
Stimulated Raman Histology and Artificial Intelligence Provide Near Real-Time Interpretation of Radical Prostatectomy Surgical Margins.

Miles P Mannas, Fang-Ming Deng, Adrian Ion-Margineanu

|Feb 10, 2024
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC).

David R Wise, Russell K Pachynski, Samuel R Denmeade

|Feb 09, 2024
Stromal-derived MAOB promotes prostate cancer growth and progression.

Tianjie Pu, Jing Wang, Jing Wei

|Jun 13, 2022
Predicting biochemical recurrence of prostate cancer with artificial intelligence.

Hans Pinckaers, Jolique van Ipenburg, Jonathan Melamed

|Jun 22, 2019
Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort.

Waqas Amin, Faina Linkov, Douglas P Landsittel

Pageof 1

Frequent Collaborators

1 joint publications

Waqas Amin

1 joint publications

Faina Linkov

1 joint publications

Hans Pinckaers

1 joint publications

Angelo De Marzo